Research Use Only - Not for human consumption. 18+ only.
CGrade CPrimarily animal or in-vitro studies; limited human dataResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use onlyKhavinson BioregulatorsOralSubcutaneous

Cartalax

Also known as: AED Tripeptide

Cartalax is a Khavinson bioregulator peptide (tripeptide: Ala-Glu-Asp) that targets cartilage and connective tissue. It supports collagen synthesis, improves joint health, and enhances tissue elasticity.

Beginner Basics

Plain-English guide to Cartalax

What it does

Cartalax is a short protein fragment that researchers use to support cartilage and connective tissue health by encouraging the body to produce more collagen and improve joint flexibility. It's typically studied for maintaining tissue structure and elasticity.

Typical dose

Researchers commonly use 10-20 mg taken by mouth daily, or 1-3 mg injected under the skin daily, for 10-20 days per cycle.

When to inject

If taking by mouth, take it with food; if injecting, timing is flexible but consistency matters more than the time of day.

Storage

Keep capsules at room temperature in a dry place; store mixed injectable solution in the refrigerator and use within the timeframe provided by your supplier.

First-timer tip

Start with the lower end of the dose range to see how your body responds, and space out your cycles (2-4 times per year) rather than using it continuously.

Research Status

CGrade CPrimarily animal or in-vitro studies; limited human dataResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only

Khavinson bioregulator - Russian research

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Supports collagen synthesis
Improves joint health
Enhances tissue elasticity
Targets fibroblast function
Supports extracellular matrix
Connective tissue support

Side Effects

Local injection site reaction
UncommonMild

Mild redness, swelling, or itching at the injection site may occur within hours and typically resolves within 24-48 hours. Ensure proper site rotation and sterile technique to minimise risk.

Mild allergic reaction
RareMild

Localised urticaria or mild rash may occur in individuals with sensitivity to peptides. Discontinue use and consult a healthcare provider if symptoms develop.

Headache
RareMild

Occasional mild headache has been reported in early treatment cycles. Typically resolves with continued use or dose adjustment.

Gastrointestinal discomfort (oral formulation)
UncommonMild

Mild nausea or stomach upset may occur with oral capsules, particularly on an empty stomach. Take with food as directed to minimise.

Lipodystrophy
UncommonModerate

Repeated injections at the same site can cause localised fat loss or thickening. Prevent by rotating injection sites systematically with each dose and maintaining at least 1 inch between injection points.

Dosing Reference

ParameterValue
Dose range10-20 mg (capsule) or 1-3 mg (injectable)
Frequency, timing and route - members only

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2-8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

SequenceMembers only

Cartalax is a tripeptide bioregulator (Ala-Glu-Asp) that acts as a tissue-specific regulator targeting cartilage and connective tissue metabolism. It stimulates collagen synthesis and fibroblast activity, enhancing extracellular matrix production and tissue repair. The peptide promotes joint elasticity and structural integrity by modulating growth factors and cellular signalling pathways involved in cartilage homeostasis.

Pathways and mechanism detail available to members

Track your Cartalax research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Cartalax is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.